• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.

作者信息

Recanatini M, Cavalli A, Hansch C

机构信息

Department of Pharmaceutical Sciences, University of Bologna, Italy.

出版信息

Chem Biol Interact. 1997 Aug 1;105(3):199-228. doi: 10.1016/s0009-2797(97)00047-1.

DOI:10.1016/s0009-2797(97)00047-1
PMID:9291997
Abstract

Considering the relevance of acetylcholinesterase inhibitors as potential agents for the treatment of the Alzheimer's disease, we have undertaken a comparative QSAR analysis aimed at individuating the physico-chemical properties governing the inhibitory activity of such compounds. The QSAR equations for 13 series of derivatives have been calculated and discussed. The series studied are all those we found in the literature suitable for a QSAR analysis and represent the three main classes of acetylcholinesterase inhibitors currently investigated, namely, physostigmine analogues, 1,2,3,4-tetrahydroacridines and benzylamines. The equations we obtained show that, within each class, the main physico-chemical properties affecting the inhibitory activity are almost the same for all the series and can be individuated by the use of proper parameters. The conclusions of this study can be summarized as follows: (a) hydrophobicity plays a critical role in both the physostigmine- and the benzylamine-derived classes; (b) electronic effects are important for the interactions carried out by the variable portion of benzylamine derivatives; and (c) steric factors are also significant, but, as in other cases, the collinearity between steric and hydrophobic parameters does not allow one to draw any final conclusion.

摘要

相似文献

1
A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.
Chem Biol Interact. 1997 Aug 1;105(3):199-228. doi: 10.1016/s0009-2797(97)00047-1.
2
Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.基于配体的毒扁豆碱类似物作为乙酰胆碱酯酶抑制剂的 3D-QSAR 研究。
Chem Biol Drug Des. 2009 Dec;74(6):571-81. doi: 10.1111/j.1747-0285.2009.00897.x. Epub 2009 Oct 15.
3
Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and characterisation.用于治疗阿尔茨海默病的新型乙酰胆碱酯酶抑制剂的发现:虚拟筛选和特性研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):491-496. doi: 10.1080/14756366.2021.1876685.
4
Inhibition of acetylcholinesterase by physostigmine analogs: conformational mobility of cysteine loop due to the steric effect of the alkyl chain.毒扁豆碱类似物对乙酰胆碱酯酶的抑制作用:由于烷基链的空间效应导致半胱氨酸环的构象流动性。
J Biochem Mol Toxicol. 2002;16(2):64-9. doi: 10.1002/jbt.10026.
5
Quantitative structure -- activity relationships (QSARs) of thrombin inhibitors: review, evaluation and comparative analysis.凝血酶抑制剂的定量构效关系(QSARs):综述、评估与比较分析。
Curr Med Chem. 2003 Apr;10(7):525-77. doi: 10.2174/0929867033457935.
6
Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.用于阿尔茨海默病的新型基于苯丝氨酸的丁酰胆碱酯酶选择性抑制剂的合成。
J Med Chem. 1999 May 20;42(10):1855-61. doi: 10.1021/jm980459s.
7
Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.具有二氯代烟碱酸部分的四氢吖啶衍生物作为有吸引力的、多效的阿尔茨海默病治疗药物。
Eur J Med Chem. 2018 Feb 10;145:760-769. doi: 10.1016/j.ejmech.2018.01.014. Epub 2018 Jan 9.
8
O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.O-羟基-或邻氨基苄基胺他克林杂合体:多功能生物金属螯合剂、抗氧化剂,以及乙酰胆碱酯酶活性和淀粉样β聚集抑制剂。
Bioorg Med Chem. 2012 Oct 1;20(19):5884-92. doi: 10.1016/j.bmc.2012.07.045. Epub 2012 Aug 15.
9
Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.苯丝氨酸及C环杂环类似物:治疗阿尔茨海默病的候选药物。
Med Res Rev. 1995 Jan;15(1):3-31. doi: 10.1002/med.2610150103.
10
SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.基于9-氨基-1,2,3,4-四氢吖啶的乙酰胆碱酯酶抑制剂的构效关系:他克林类似物的合成、酶抑制活性、定量构效关系及基于结构的比较分子场分析
J Med Chem. 2000 May 18;43(10):2007-18. doi: 10.1021/jm990971t.

引用本文的文献

1
ABCpred: a webserver for the discovery of acetyl- and butyryl-cholinesterase inhibitors.ABCpred:用于发现乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂的网络服务器。
Mol Divers. 2022 Feb;26(1):467-487. doi: 10.1007/s11030-021-10292-6. Epub 2021 Oct 5.
2
Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease.用于预测乙酰胆碱酯酶和 BACE1 双重抑制剂治疗阿尔茨海默病活性的机器学习模型。
Mol Divers. 2022 Jun;26(3):1501-1517. doi: 10.1007/s11030-021-10282-8. Epub 2021 Jul 29.
3
In Silico Studies in Drug Research Against Neurodegenerative Diseases.
计算机药物研究在神经退行性疾病防治中的应用
Curr Neuropharmacol. 2018;16(6):664-725. doi: 10.2174/1570159X15666170823095628.
4
Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.新型哌啶酮接枝乙酰胆碱酯酶抑制剂的设计与合成
Bioorg Med Chem Lett. 2017 Jan 15;27(2):228-231. doi: 10.1016/j.bmcl.2016.11.065. Epub 2016 Nov 24.
5
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment.7-甲氧基他克林-对茴香胺杂合物作为用于治疗阿尔茨海默病的新型双结合位点乙酰胆碱酯酶抑制剂
Molecules. 2015 Dec 10;20(12):22084-101. doi: 10.3390/molecules201219836.
6
Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase.统计分子设计、协方差分析和参考模型在定量构效关系中的益处:以乙酰胆碱酯酶为例的研究
J Comput Aided Mol Des. 2015 Mar;29(3):199-215. doi: 10.1007/s10822-014-9808-1. Epub 2014 Oct 29.
7
QSAR studies on N-aryl derivative activity towards Alzheimer's disease.关于N-芳基衍生物对阿尔茨海默病活性的定量构效关系研究。
Molecules. 2009 Apr 7;14(4):1448-55. doi: 10.3390/molecules14041448.
8
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.人类乙酰胆碱酯酶活性中心三个近端残基的“芳香补丁”允许与抑制剂进行多种相互作用模式。
Biochem J. 1998 Oct 1;335 ( Pt 1)(Pt 1):95-102. doi: 10.1042/bj3350095.